List of Tables
Table 1. Global Thrombogenic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Thrombogenic Agents Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Thrombogenic Agents Market Competitive Situation by Manufacturers in 2024
Table 4. Global Thrombogenic Agents Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Thrombogenic Agents Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Thrombogenic Agents Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Thrombogenic Agents Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Thrombogenic Agents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Thrombogenic Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Thrombogenic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Thrombogenic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Thrombogenic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Thrombogenic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombogenic Agents as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Thrombogenic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Thrombogenic Agents Sales by Region (2020-2025) & (Units)
Table 18. Global Thrombogenic Agents Sales Market Share by Region (2020-2025)
Table 19. Global Thrombogenic Agents Sales by Region (2026-2031) & (Units)
Table 20. Global Thrombogenic Agents Sales Market Share by Region (2026-2031)
Table 21. Global Thrombogenic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Thrombogenic Agents Revenue Market Share by Region (2020-2025)
Table 23. Global Thrombogenic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Thrombogenic Agents Revenue Market Share by Region (2026-2031)
Table 25. North America Thrombogenic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Thrombogenic Agents Sales by Country (2020-2025) & (Units)
Table 27. North America Thrombogenic Agents Sales by Country (2026-2031) & (Units)
Table 28. North America Thrombogenic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Thrombogenic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Thrombogenic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Thrombogenic Agents Sales by Country (2020-2025) & (Units)
Table 32. Europe Thrombogenic Agents Sales by Country (2026-2031) & (Units)
Table 33. Europe Thrombogenic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Thrombogenic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Thrombogenic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Thrombogenic Agents Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Thrombogenic Agents Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Thrombogenic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Thrombogenic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Thrombogenic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Thrombogenic Agents Sales by Country (2020-2025) & (Units)
Table 42. Latin America Thrombogenic Agents Sales by Country (2026-2031) & (Units)
Table 43. Latin America Thrombogenic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Thrombogenic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Thrombogenic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Thrombogenic Agents Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Thrombogenic Agents Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Thrombogenic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Thrombogenic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Thrombogenic Agents Sales (Units) by Type (2020-2025)
Table 51. Global Thrombogenic Agents Sales (Units) by Type (2026-2031)
Table 52. Global Thrombogenic Agents Sales Market Share by Type (2020-2025)
Table 53. Global Thrombogenic Agents Sales Market Share by Type (2026-2031)
Table 54. Global Thrombogenic Agents Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Thrombogenic Agents Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Thrombogenic Agents Revenue Market Share by Type (2020-2025)
Table 57. Global Thrombogenic Agents Revenue Market Share by Type (2026-2031)
Table 58. Global Thrombogenic Agents Price (US$/Unit) by Type (2020-2025)
Table 59. Global Thrombogenic Agents Price (US$/Unit) by Type (2026-2031)
Table 60. Global Thrombogenic Agents Sales (Units) by Application (2020-2025)
Table 61. Global Thrombogenic Agents Sales (Units) by Application (2026-2031)
Table 62. Global Thrombogenic Agents Sales Market Share by Application (2020-2025)
Table 63. Global Thrombogenic Agents Sales Market Share by Application (2026-2031)
Table 64. Global Thrombogenic Agents Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Thrombogenic Agents Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Thrombogenic Agents Revenue Market Share by Application (2020-2025)
Table 67. Global Thrombogenic Agents Revenue Market Share by Application (2026-2031)
Table 68. Global Thrombogenic Agents Price (US$/Unit) by Application (2020-2025)
Table 69. Global Thrombogenic Agents Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Thrombogenic Agents Product
Table 74. Roche Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Thrombogenic Agents Product
Table 79. Merck Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Thrombogenic Agents Product
Table 84. Pfizer Recent Developments/Updates
Table 85. BristolMyers Squibb Company Information
Table 86. BristolMyers Squibb Description and Business Overview
Table 87. BristolMyers Squibb Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. BristolMyers Squibb Thrombogenic Agents Product
Table 89. BristolMyers Squibb Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AbbVie Thrombogenic Agents Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Sanofi Company Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Thrombogenic Agents Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Johnson And Johnson Company Information
Table 101. Johnson And Johnson Description and Business Overview
Table 102. Johnson And Johnson Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson And Johnson Thrombogenic Agents Product
Table 104. Johnson And Johnson Recent Developments/Updates
Table 105. Boehringer Ingelheim Company Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Boehringer Ingelheim Thrombogenic Agents Product
Table 109. Boehringer Ingelheim Recent Developments/Updates
Table 110. Amgen Company Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Amgen Thrombogenic Agents Product
Table 114. Amgen Recent Developments/Updates
Table 115. Novo Nordisk Company Information
Table 116. Novo Nordisk Description and Business Overview
Table 117. Novo Nordisk Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Novo Nordisk Thrombogenic Agents Product
Table 119. Novo Nordisk Recent Developments/Updates
Table 120. Zhongbao Pharmaceutical Company Information
Table 121. Zhongbao Pharmaceutical Description and Business Overview
Table 122. Zhongbao Pharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Zhongbao Pharmaceutical Thrombogenic Agents Product
Table 124. Zhongbao Pharmaceutical Recent Developments/Updates
Table 125. Tiancheng Pharmaceutical Group Company Information
Table 126. Tiancheng Pharmaceutical Group Description and Business Overview
Table 127. Tiancheng Pharmaceutical Group Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Tiancheng Pharmaceutical Group Thrombogenic Agents Product
Table 129. Tiancheng Pharmaceutical Group Recent Developments/Updates
Table 130. Chongqing Laimei Pharmaceutical Company Information
Table 131. Chongqing Laimei Pharmaceutical Description and Business Overview
Table 132. Chongqing Laimei Pharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Chongqing Laimei Pharmaceutical Thrombogenic Agents Product
Table 134. Chongqing Laimei Pharmaceutical Recent Developments/Updates
Table 135. Nuokang Pharmaceutical Group Company Information
Table 136. Nuokang Pharmaceutical Group Description and Business Overview
Table 137. Nuokang Pharmaceutical Group Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Nuokang Pharmaceutical Group Thrombogenic Agents Product
Table 139. Nuokang Pharmaceutical Group Recent Developments/Updates
Table 140. Shanghai RAAS Blood Products Company Information
Table 141. Shanghai RAAS Blood Products Description and Business Overview
Table 142. Shanghai RAAS Blood Products Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Shanghai RAAS Blood Products Thrombogenic Agents Product
Table 144. Shanghai RAAS Blood Products Recent Developments/Updates
Table 145. Shandong Taibang Biotechnology Company Information
Table 146. Shandong Taibang Biotechnology Description and Business Overview
Table 147. Shandong Taibang Biotechnology Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Shandong Taibang Biotechnology Thrombogenic Agents Product
Table 149. Shandong Taibang Biotechnology Recent Developments/Updates
Table 150. Boya Biopharmaceutical Company Information
Table 151. Boya Biopharmaceutical Description and Business Overview
Table 152. Boya Biopharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Boya Biopharmaceutical Thrombogenic Agents Product
Table 154. Boya Biopharmaceutical Recent Developments/Updates
Table 155. Chongqing Dikang Yangtze River Pharmaceutical Company Information
Table 156. Chongqing Dikang Yangtze River Pharmaceutical Description and Business Overview
Table 157. Chongqing Dikang Yangtze River Pharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Chongqing Dikang Yangtze River Pharmaceutical Thrombogenic Agents Product
Table 159. Chongqing Dikang Yangtze River Pharmaceutical Recent Developments/Updates
Table 160. Wuzhong Medicine Suzhou Pharmaceutical Company Information
Table 161. Wuzhong Medicine Suzhou Pharmaceutical Description and Business Overview
Table 162. Wuzhong Medicine Suzhou Pharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Wuzhong Medicine Suzhou Pharmaceutical Thrombogenic Agents Product
Table 164. Wuzhong Medicine Suzhou Pharmaceutical Recent Developments/Updates
Table 165. Jiangsu Yabang Aipson Pharmaceutical Company Information
Table 166. Jiangsu Yabang Aipson Pharmaceutical Description and Business Overview
Table 167. Jiangsu Yabang Aipson Pharmaceutical Thrombogenic Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Jiangsu Yabang Aipson Pharmaceutical Thrombogenic Agents Product
Table 169. Jiangsu Yabang Aipson Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Thrombogenic Agents Distributors List
Table 173. Thrombogenic Agents Customers List
Table 174. Thrombogenic Agents Market Trends
Table 175. Thrombogenic Agents Market Drivers
Table 176. Thrombogenic Agents Market Challenges
Table 177. Thrombogenic Agents Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Thrombogenic Agents
Figure 2. Global Thrombogenic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Thrombogenic Agents Market Share by Type: 2024 & 2031
Figure 4. Antithrombin Ⅲ Dependent Anticoagulants Product Picture
Figure 5. Vitamin K Antagonists Product Picture
Figure 6. Direct Thrombin Inhibitors Product Picture
Figure 7. Factor Xa Inhibitors Product Picture
Figure 8. Others Product Picture
Figure 9. Global Thrombogenic Agents Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Thrombogenic Agents Market Share by Application: 2024 & 2031
Figure 11. Stop Bleeding
Figure 12. Tumor Treatment
Figure 13. Cardiovascular Disease Treatment
Figure 14. Research And Drug Development
Figure 15. Others
Figure 16. Global Thrombogenic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Thrombogenic Agents Market Size (2020-2031) & (US$ Million)
Figure 18. Global Thrombogenic Agents Sales (2020-2031) & (Units)
Figure 19. Global Thrombogenic Agents Average Price (US$/Unit) & (2020-2031)
Figure 20. Thrombogenic Agents Report Years Considered
Figure 21. Thrombogenic Agents Sales Share by Manufacturers in 2024
Figure 22. Global Thrombogenic Agents Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Thrombogenic Agents Players: Market Share by Revenue in Thrombogenic Agents in 2024
Figure 24. Thrombogenic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Thrombogenic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Thrombogenic Agents Sales Market Share by Country (2020-2031)
Figure 27. North America Thrombogenic Agents Revenue Market Share by Country (2020-2031)
Figure 28. United States Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Thrombogenic Agents Sales Market Share by Country (2020-2031)
Figure 31. Europe Thrombogenic Agents Revenue Market Share by Country (2020-2031)
Figure 32. Germany Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Thrombogenic Agents Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Thrombogenic Agents Revenue Market Share by Region (2020-2031)
Figure 39. China Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Thrombogenic Agents Sales Market Share by Country (2020-2031)
Figure 47. Latin America Thrombogenic Agents Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Thrombogenic Agents Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Thrombogenic Agents Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Thrombogenic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Thrombogenic Agents by Type (2020-2031)
Figure 58. Global Revenue Market Share of Thrombogenic Agents by Type (2020-2031)
Figure 59. Global Thrombogenic Agents Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Thrombogenic Agents by Application (2020-2031)
Figure 61. Global Revenue Market Share of Thrombogenic Agents by Application (2020-2031)
Figure 62. Global Thrombogenic Agents Price (US$/Unit) by Application (2020-2031)
Figure 63. Thrombogenic Agents Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
